SCHEMBL4774938

SCHEMBL4774938

CC(=O)N1CCC(CNC(=O)c2ccc(N(Cc3cccc(Cl)c3Cl)S(C)(=O)=O)cc2)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.49
ALDH1A1 P00352 4/20 0.49
GAA P10253 2/20 0.47
POLB P06746 1/20 0.45
LMNA P02545 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
NPSR1 Q6W5P4 2/20 0.41
KDM4E B2RXH2 2/20 0.40
PKM P14618 1/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
GNRHR P30968 1/20 0.39
CXCR3 P49682 2/20 0.39
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5571930 0.93 ALDH1A1 (0.56) RECQLALDH1A1GAAPOLBLMNA
SCHEMBL4767621 0.90 RECQL (0.49) RECQLALDH1A1GAAPOLBLMNA
SCHEMBL5567967 0.88 KDM4E (0.58) RECQLALDH1A1GAAPOLBLMNA
SCHEMBL5571881 0.84 ALDH1A1 (0.51) RECQLALDH1A1GAALMNAMEN1
SCHEMBL4775217 0.84 RECQL (0.56) RECQLALDH1A1GAAPOLBLMNA
SCHEMBL4775167 0.83 KDM4E (0.39) ALDH1A1GAALMNAKDM4EPKM
SCHEMBL14497661 0.81 KDM4E (0.62) RECQLALDH1A1GAAPOLBLMNA
SCHEMBL5571955 0.81 ACKR3 (0.49) RECQLALDH1A1GAAPOLBKMT2A
SCHEMBL4768090 0.79 ALDH1A1 (0.46) RECQLALDH1A1GAAPOLBLMNA
SCHEMBL14497662 0.79 GAA (0.58) RECQLALDH1A1GAAPOLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1942888-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS Cytokinetics, Inc. (US) 2008-07-16 EP claimed
US-20070135435-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INCORPORATED 2007-06-14 US claimed
WO-2007056078-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS CYTOKINETICS, INC. (US) 2007-05-18 WO claimed
US-20070135435-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INCORPORATED 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135435-A1 Certain chemical entities, compositions, and methods KIF5B, KIF2C, PLK1 RECQL 139/4885ALDH1A1 2159/4885GAA 466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.